Jun. 5 at 9:06 AM
$SNGX
$SNGX Scientists forecast future Ebola outbreaks will have less impact as vaccine development for Bundibugyo gets fast-tracked. Funding from CEPI is ramping up, but experts warn delivery remains a major challenge due to the lack of infrastructure in remote, rural Africa.
This is EXACTLY where
$SNGX comes in with its heat-stable ThermoVax platform—no cold chain needed. They are clearly on the radar for major non-dilutive funding. 🚀
https://www.thenationalnews.com/news/2026/06/05/ebola-will-have-less-impact-in-future-scientists-say/
$CODX $MRNA
